PAR 3.92% 24.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-3836

  1. 301 Posts.
    lightbulb Created with Sketch. 84
    It will depend on feedback from the agencies, expert contractors, internal experts etc etc, given we are basically putting ourselves into a situation whereby we do need a big pharma to come in and take us to market. We need to be packaged up beyond reasonable doubt, if we are going to command the enormous figure Paul and us all want.

    As it turns out Big Pharma and fda ema tga aren’t charities. We are all doing the heavy lifting, none more so than Paul. No one wants to fail on a technicality.

    I’ll be patient whilst this plays out so long as Paul and our scientists hang around. It’s getting close, very close. Fascinating viewing from the nose bleed section, but all I have to do is park my behind and wait. Personally, I can do that for now.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.010(3.92%)
Mkt cap ! $85.70M
Open High Low Value Volume
24.5¢ 25.0¢ 24.0¢ $59.66K 241.2K

Buyers (Bids)

No. Vol. Price($)
4 78837 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 36290 1
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.